Page 29 - Pharma

Sun Pharma, ICMR ink pact for Malaria Free India initiative

Malaria Free India PPP project to demonstrate malaria elimination in over 1,200 villages of Mandla district by FY21

Plant to make ethanol from cellulosic biomass inaugurated at Kashipur

The plant is based on indigenous technology, developed by DBT-ICT Centre for Energy Biosciences, to convert lingo-cellulosic biomass to ethanol

Novo Nordisk to invest Euro 100 mn for new facility in France

The expansion will help Novo Nordisk meet the increasing worldwide demand for its diabetes medicines

Lubrizol LifeSciences to expand manufacturing capacity at Particle Sciences

The capacity will include both sterile and non-sterile space with complete lyophilisation and filling operations

France's Urgo Group partners Eucare Pharma for wound care

By creating treatment tailored to each wound type, increasing education and awareness, Eucare and Urgo aim at becoming the caring partner to all major hospitals across the country

Wacker opens polysilicon production facility in US

The new facility, Wacker's largest single investment of some $ 2.5 billion, will produce 20,000 metric tonne of polysilicon, which finds application in photovoltaic systems

Alembic Pharma forms JV with Orbicular for derma products

The JV will develop, manufacture and commercialise dermatology products for global markets

Market for infection prevention products & services in US to exceed $ 27 bn

Increasing pressures on healthcare facilities to decrease rates of healthcare-associated infections (HAIs) is expected to boost revenues in this sector, says a Freedonia report

ICMR and Japan's NIID to collaborate for antimicrobial resistance research

Two sides will collaborate on the development of integrated surveillance program covering epidemiology data and genomic data of antimicrobial resistance in each country

Sanofi to invest Euro 300 mn in Belgium plant to expand biologics capabilities

The additional investment will support production of monoclonal antibodies

Chinese drug discovery firm WuXi AppTec acquires Germany's Crelux

Acquisition enhances WuXi's structure-based drug discovery capabilities and establishes WuXi research facilities within Europe

Dr Reddy's launches migraine drug Zembrace SymTouch in US

The company had received the US FDA's approval for Zembrace SymTouch (sumatriptan injection) for the acute treatment of migraine in January 2016

Swedish firm Recipharm buys Kemwell businesses for Rs 1360 cr

Two separate agreements have been signed for this - while first comprises US and Swedish operations, the second comprises operations in India

Cabb begins production of monochloroacetic acid in China

The plant, an investment of Euro 15 million carried out in a joint venture with Chinese company Jining Gold Power, will produce around 25,000 metric tonnes of MCA

Cipla partners with global NGO FIND for hepatitis C cure & diagnosis

Both sides will focus on areas such as building diagnostic capacity & an enabling environment for HCV treatment scale-up

South Africa's Adcock Ingram sells Indian business to Samara Capital for Rs 151 crores

The divested business was acquired by Adcock Ingram in 2013 from Cosme Farma Laboratories for about Rs 328 crore to tap the Indian pharmaceutical segment

Tips to reduce hazards of blue violet light for healthy eyes

With increased usage of modern electronic devices such as computers, cell phones, CFLs, LEDs, etc people today are exposed to high-level of blue light which can cause damage to retina cells

Internet of Things to transform global healthcare industry

Rather than current specialties, future healthcare will be organised around digital solutions like monitoring, diagnostics, and predictive analytics, connecting diverse conditions, says Lux Research

Lupin to co-market Novartis' asthma drug in India

Novartis Healthcare will continue to market Sequadra (indacaterol/glycopyrronium inhaler), while Lupin will promote the inhaler under the brand name Loftair in India

MannKind regains marketing rights for inhaled insulin Afrezza from Sanofi

Transition ensures inhalable insulin will continue to be available to adults with diabetes